DPP4 and Insulin resistance: Compared to baseline, plasma LPS and the activity of dipeptidyl peptidase-IV (DPP-IV) decreased in the intervention group, suggesting two potential mechanisms for the decreased insulin resistance: decreased endotoxemia and increased glucagon-like peptide 1 (GLP-1), respectively.